AZN vs NHI · P/E 28, $288.38B cap vs P/E 22, rev $54.4M
AstraZeneca PLC (AZN) versus National Health Investors Inc (NHI) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
National Health Investors Inc (NHI) is a reit - healthcare facilities company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported NHI revenue for 2024-12-31 was $54.4M. Net income was $136.6M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. NHI currently screens at market cap $3.31B and trailing P/E 22.4.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. NHI currently screens at market cap $3.31B and trailing P/E 22.4.
Not investment advice. Open the AZN and NHI stock pages for the full models.
Not investment advice.